Photo taken from Houman Sotoudeh/X
Aug 20, 2024, 10:46
Houman Sotoudeh: MRI Math, AI Platform-Cyber Device for GBM is now FDA-approved
Houman Sotoudeh, Associate Professor of Neuroradiology and Neurology at University of Alabama at Birmingham, shared on X:
“I’m thrilled to share that the AI Platform-Cyber Device for glioblastoma multiforme (GBM), which I had the privilege of helping to develop, is now FDA-approved and commercially available!”
Additional information.
Source: Houman Sotoudeh/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 8, 2025, 17:21
Aug 8, 2025, 17:21
Aug 8, 2025, 16:46
Aug 8, 2025, 16:41
Aug 8, 2025, 16:31
Aug 8, 2025, 16:11
Aug 8, 2025, 15:57
Aug 8, 2025, 15:54
Aug 8, 2025, 15:49